Turtle Creek ******* et Management, an investment management company, recently published its Q1 2026 report. A copy is available to download here. Turtle Creek ******* et Management's Q1 2026 report covers key market factors currently at play. The escalation of the Iran conflict has pushed oil and gas prices higher, while AI's impact on various sectors, especially enterprise software, continues to grow. The firm increased rebalancing activity in the quarter amid heightened market volatility and the momentum in AI-related trades. In this environment, Turtle Creek Equity Fund returned -4.8% for the quarter. Additionally, you can review the Portfolio's top 5 holdings to see its best picks for 2026.
In its first-quarter 2026 investor letter, Turtle Creek ******* et Management highlighted The Pennant Group, Inc. (NASDAQ:PNTG). The Pennant Group, Inc. (NASDAQ:PNTG) is a healthcare company that offers home health services, and hospice services. On June 17, 2026, The Pennant Group, Inc. (NASDAQ:PNTG) closed at $34.58 per share. One-month return of The Pennant Group, Inc. (NASDAQ:PNTG) was -0.03%, and its shares gained 23.24% over the past 52 weeks. The Pennant Group, Inc. (NASDAQ:PNTG) has a market capitalization of $1.20 billion.
Turtle Creek ******* et Management stated the following regarding The Pennant Group, Inc. (NASDAQ:PNTG) in its Q1 2026 investor letter:
"The Pennant Group, Inc. (NASDAQ:PNTG) provides home health care and hospice services in the United States and was 'spun' out of The Ensign Group six years ago. Ensign is the largest and leading skilled nursing facilities operator in the United States, and we added Ensign to the portfolio a year ago. Our work on Ensign led us to Pennant. Like Ensign, the company has a highly decentralized, "locally-led" operating model. Rather than relying on a rigid top-down corporate structure, Pennant empowers local clinical and operational leaders to make decisions tailored to the specific needs of their respective communities. This approach fosters entrepreneurship, accountability, and a strong focus on delivering high-quality patient care."
The Pennant Group, Inc. (NASDAQ:PNTG) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 24 hedge fund portfolios held The Pennant Group, Inc. (NASDAQ:PNTG) at the end of the first quarter, compared to 30 in the previous quarter. In Q1 2026, The Pennant Group, Inc. (NASDAQ:PNTG) reported revenue of $285.4 million, up $75.5 million, or 36%, from Q1 2025. While we acknowledge the potential of The Pennant Group, Inc. (NASDAQ:PNTG) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In its first-quarter 2026 investor letter, Turtle Creek ******* et Management highlighted The Pennant Group, Inc. (NASDAQ:PNTG). The Pennant Group, Inc. (NASDAQ:PNTG) is a healthcare company that offers home health services, and hospice services. On June 17, 2026, The Pennant Group, Inc. (NASDAQ:PNTG) closed at $34.58 per share. One-month return of The Pennant Group, Inc. (NASDAQ:PNTG) was -0.03%, and its shares gained 23.24% over the past 52 weeks. The Pennant Group, Inc. (NASDAQ:PNTG) has a market capitalization of $1.20 billion.
Turtle Creek ******* et Management stated the following regarding The Pennant Group, Inc. (NASDAQ:PNTG) in its Q1 2026 investor letter:
"The Pennant Group, Inc. (NASDAQ:PNTG) provides home health care and hospice services in the United States and was 'spun' out of The Ensign Group six years ago. Ensign is the largest and leading skilled nursing facilities operator in the United States, and we added Ensign to the portfolio a year ago. Our work on Ensign led us to Pennant. Like Ensign, the company has a highly decentralized, "locally-led" operating model. Rather than relying on a rigid top-down corporate structure, Pennant empowers local clinical and operational leaders to make decisions tailored to the specific needs of their respective communities. This approach fosters entrepreneurship, accountability, and a strong focus on delivering high-quality patient care."
The Pennant Group, Inc. (NASDAQ:PNTG) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 24 hedge fund portfolios held The Pennant Group, Inc. (NASDAQ:PNTG) at the end of the first quarter, compared to 30 in the previous quarter. In Q1 2026, The Pennant Group, Inc. (NASDAQ:PNTG) reported revenue of $285.4 million, up $75.5 million, or 36%, from Q1 2025. While we acknowledge the potential of The Pennant Group, Inc. (NASDAQ:PNTG) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
1 month ago
